• Home
  • Courses
  • Features
    • PACUPrep
    • Masterclasses
    • Reference Library
    • Live Seminars
    • Patient Cases
    • Literature Review
    • Our CE Courses
    • Blog Posts
      • Pharmacy Friday Pearls
  • PACULit Newsletter
  • PACUPrep
    • PACUPrep MPJE
  • About Us
    • Contact
  • Dashboard
  • Login
  • Home
  • Courses
  • Features
    • PACUPrep
    • Masterclasses
    • Reference Library
    • Live Seminars
    • Patient Cases
    • Literature Review
    • Our CE Courses
    • Blog Posts
      • Pharmacy Friday Pearls
  • PACULit Newsletter
  • PACUPrep
    • PACUPrep MPJE
  • About Us
    • Contact
  • Dashboard
  • Login
Sign in Sign up
Pharmacy & Acute Care University
Pharmacy & Acute Care University
  • Home
  • Courses
  • Features
    • PACUPrep
    • Masterclasses
    • Reference Library
    • Live Seminars
    • Patient Cases
    • Literature Review
    • Our CE Courses
    • Blog Posts
      • Pharmacy Friday Pearls
  • PACULit Newsletter
  • PACUPrep
    • PACUPrep MPJE
  • About Us
    • Contact
  • Dashboard
  • Login

Tag: Post-Myocardial Infarction

Pitt B, et al. “Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction”. The New England Journal of Medicine. 2003. 348(14):1309-21.

PACULit: Eplerenone in Post-MI LV Dysfunction Resources PubMed Full Text Contents Article Identification Quick Reference Summary Core Clinical Question Background Methods Summary Detailed Results Authors’…

jimmyleepruittgmail-com
Jimmy Pruitt January 27, 2025
0 Comments

CAST Trial. Mortality and morbidity in patients receiving Encainide, Flecainide, or Placebo

Table of Contents Clinical Literature Summary Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial Authors (Top 5): D.…

jimmyleepruittgmail-com
Jimmy Pruitt November 23, 2024
0 Comments
© 2025 - Pharmacy & Acute Care University